Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Emergency Department Atrial Fibrillation Oral Diltiazem Observation Protocol

NCT05391893 is registered in ClinicalTrials.gov with Corewell Health South as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05391893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Emergency Department Atrial Fibrillation Oral Diltiazem Observation Protocol
Lead sponsor
Corewell Health South
Phase
Phase 4
Overall status
Completed
Start date
June 19, 2020
Completion date
April 1, 2023
Enrollment
444 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.